Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in refractory cirrhotic ascites with type 2 diabetes
ChiCTR2500104785Phase 4Completed
- Sponsor
- Baoding People's Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in Refractory ascites, Cirrhosis, type 2 diabetes mellitus (T2DM), pleural effusion, sponsored by Baoding People's Hospital. Started Jun 2025; status: completed.
02
Drugs
empagliflozin
03
Conditions
Refractory ascitesCirrhosistype 2 diabetes mellitus (T2DM)pleural effusion
Beyond the preview
Go deeper on ChiCTR2500104785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104785.